STATE OF THE ART PHARMACOLOGICAL THERAPY FOR ATRIAL FIBRILLATION

QR Code

STATE OF THE ART PHARMACOLOGICAL THERAPY FOR ATRIAL FIBRILLATION

Pharmacological therapy remains the primary approach to atrial fibrillation (AF). Management of all AF patients includes the decision on rate or rhythm control. The latter means antiarrhythmic drugs application that are being selected primarily by safety reasons and depend on individual characterist...

Full description

Saved in:

Bibliographic Details
Main Authors:	S. G. Kanorsky, Yu. S. Kovalenko
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2017-08-01
Series:	Российский кардиологический журнал
Subjects:	atrial fibrillation antiarrhythmic drugs rate control rhythm control
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/1664
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Atrial fibrillation: Yesterday, today, and tomorrow
by: S. G. Kanorskiy, et al.
Published: (2025-06-01)

Personified approach to diagnostics and treatment of atrial fibrillation. Diagnostic stage (part 1)
by: E. A. Praskurnichii, et al.
Published: (2021-06-01)

Personified approach to diagnostics and treatment of atrial fibrillation. Diagnostic stage (part 2)
by: E. A. Praskurnichii, et al.
Published: (2021-06-01)

Safety and Effectiveness of Pharmacologic Conversion of Atrial Fibrillation and Flutter: Results of Multicenter Trial. Part II: Assessment of Safety
by: N. Yu. Mironov, et al.
Published: (2021-11-01)

Safety and Effectiveness of Pharmacologic Conversion of Atrial Fibrillation and Flutter: Results of Multicenter Trial. Part I: Study Rationale, Design and Assessment of Effectiveness
by: N. Yu. Mironov, et al.
Published: (2021-05-01)

ATRIAL FIBRILLATION AND CHRONIC HEART FAILURE: PRACTICAL ASPECTS AND DISCUSSION ISSUES OF RATIONAL PHARMACOTHERAPY
by: Yu. А. Bunin, et al.
Published: (2017-12-01)

ASSOCIATION OF RS2200733 POLYMORPHISM WITH ANTIARRHYTHMIC THERAPY AND PROGRESSION OF ATRIAL FIBRILLATION IN THE UZBEK POPULATIO
by: R. D. Kurbanov, et al.
Published: (2020-12-01)

Antiarrhythmic therapy in the treatment of atrial fibrillation: yesterday, today, tomorrow
by: V. I. Podzolkov, et al.
Published: (2019-06-01)

Modern principles of atrial fibrillation therapy in patients with chronic heart failure
by: A. I. Tarzimanova, et al.
Published: (2005-06-01)

FEATURES OF THE CARDIOVERSION IN ATRIAL FLUTTER AND FIBRILLATION IN ERA OF NEW ANTICOAGULANTS: PRACTICAL CARDIOLOGIST VIEW
by: S. A. Zenin, et al.
Published: (2015-09-01)

ANALYSIS OF THE RESULTS OF FIVE YEAR PATIENTS FOLLOW-UP IN PAROXYSMAL ATRIAL FIBRILLATION TREATED WITH ANTIARRHYTHMICS
by: T. A. Rybakova, et al.
Published: (2018-08-01)

Effect of Amiodarone, Sotalol and Bisoprolol on Heart Rate Variability in Patients with Atrial Fibrillation
by: E. P. Popova, et al.
Published: (2020-11-01)

Association of Rate‐Control and Antiarrhythmic Medication Use and Risk of Ischemic Stroke and Death in Patients on Dialysis With Atrial Fibrillation
by: Benjamin Lidgard, et al.
Published: (2025-06-01)

ATRIAL FIBRILLATION: CURRENT PROBLEMS AND PROSPECTS OF MEDICAL CARE, TREATMENT AND PREVENTION
by: Ju. P. Skirdenko, et al.
Published: (2016-05-01)

Antiarrhythmic therapy for atrial fibrillation: current guidelines of the European Society of Cardiology and the European Association for Cardio-Thoracic Surgery (ESC/EACTS)
by: A. I. Tarzimanova, et al.
Published: (2021-09-01)

Atrial Fibrillation in Diabetes: Pathogenesis and Targeted Rhythm Control Strategies
by: Konstantinos Grigoriou, et al.
Published: (2025-07-01)

PAROXYSMAL ATRIAL FIBRILLATION: CHOICE OF CARDIOVERSION THERAPY
by: B. A. Tatarskii
Published: (2015-12-01)

Personalized Medicine in the Treatment of Atrial Fibrillation: Myth or Reality?
by: V. I. Podzolkov, et al.
Published: (2019-03-01)

2020 Clinical guidelines for Atrial fibrillation and atrial flutter
by: M. G. Arakelyan, et al.
Published: (2021-08-01)

Propafenone efficacy in paroxysmal atrial fibrillation
by: V. V. Skibitsky, et al.
Published: (2004-12-01)

PROSPECTS FOR THE TREATMENT OF PATIENTS WITH ATRIAL FIBRILLATION
by: V. A. Sulimov, et al.
Published: (2016-01-01)

Antiarrhythmic drug therapy after atrial fibrillation ablation: data of the ESC-EHRA registry
by: L. E. Korobchenko, et al.
Published: (2020-06-01)

Predictors of Atrial Fibrillation Recurrence After Catheter Ablation: A State-of-the-Art Review
by: Roopeessh Vempati, et al.
Published: (2025-04-01)

Differentiated approach to rhythm conversion in patients with atrial fibrillation and flutter
by: A. G. Pronin, et al.
Published: (2021-12-01)

Avoiding anticoagulation drugs for postoperative atrial fibrillation enabled successful conservative treatment of left atrial dissection: a case report
by: Kentaro Kiryu, et al.
Published: (2021-05-01)

Propafenone in complex anti-recurrent therapy of persistent atrial fibrillation
by: V. V. Skibitsky, et al.
Published: (2007-08-01)

COMPARISON OF DIRECT COSTS OF DABIGATRAN AND WARFARIN THERAPY IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION DURING PREPARATION FOR ELECTIVE CARDIOVERSION IN THE REAL CLINICAL PRACTICE
by: L. E. Kuvshinova, et al.
Published: (2015-09-01)

CURRENT PRINCIPLES AND TRENDS OF ATRIAL FIBRILLATION PHARMACOTHERAPY
by: Yu. A. Bunin
Published: (2016-01-01)

Paroxysmal atrial fibrillation: treatment choice
by: B. A. Tatarsky
Published: (2007-06-01)

Clinical and Pathogenetic Assessment of Relationships Between the Dynamics of Body Weight Changes and Atrial Fibrillation in Patients with Primary Obesity
by: E. A. Praskurnichiy, et al.
Published: (2021-09-01)

ADJUSTMENT OF PHARMACOLOGICAL ANTIARRHYTHMIC THERAPY IN PATIENTS WITH PAROXYSMAL ATRIAL FIBRILLATION DURING SERIAL TESTING OF ANTIARRHYTHMIC DRUGS WITH TRANSESOPHAGEAL ELECTROPHYSIOLOGICAL STUDIES
by: K. A. Skiba, et al.
Published: (2003-06-01)

Early Rhythm Control of Atrial Fibrillation in Cancer Survivors: A Nationwide Population‐Based Study
by: Seokmoon Han, et al.
Published: (2025-07-01)

CORRELATION BETWEEN HEART RHYTHM AND SYMPTOMS IN PATIENTS WITH PAROXYSMAL ATRIAL FIBRILLATION AFTER CATHETER ABLATION AND ANTIARRHYTHMIC THERAPY BASED ON DATA OBTAINED FROM IMPLANTABLE CARDIAC MONITORS
by: A. A. Simonyan, et al.
Published: (2016-09-01)

2016 ESC GUIDELINES FOR THE MANAGEMENT OF ATRIAL FIBRILLATION DEVELOPEDIN COLLABORATION WITH EACTS
by: Paulus Kirchhof, et al.
Published: (2017-08-01)

Tactics of Antiarrhythmic Therapy in Comorbid Elderly and Senile Patients with Paroxysmal and Recurrent Atrial Fibrillation
by: M. H. Fedorova, et al.
Published: (2018-11-01)

CHANGES IN THE LEVEL OF NATRIURETIC PEPTIDES IN PATIENTS WITH ATRIAL FIBRILLATION TREATED WITH ANTIARRHYTHMIC DRUGS
by: V. I. Podzolkov, et al.
Published: (2015-09-01)

Effectiveness of сavutilide in restoring sinus rhythm in patients with atrial fibrillation and flutter following prior unsuccessful electrical cardioversion
by: Kh. M. Dzaurova, et al.
Published: (2025-06-01)

Effectiveness of Class IC Antiarrhythmics in Patients with Paroxysmal Form of Atrial Fibrillation in Absence of Structural Heart Disease
by: D. A. Tsaregorodtsev, et al.
Published: (2023-05-01)

Comparing the Impact of Different Antiarrhythmic Classes on Clinical Outcomes Following Atrial Fibrillation Catheter Ablation
by: Andrej Belančić, et al.
Published: (2025-07-01)

ANTITHROMBOTIC THERAPY AT AN ATRIAL FIBRILLATION: OLD PROBLEMS AND NEW SOLUTIONS
by: M. Yu. Gilyarov, et al.
Published: (2016-01-01)